// App-Quantinova.ai

15545 2014 AHA : Incremental Prognostic Value of Echocardiographic Markers of Left Ventricular Remodeling and Diastolic Function in the Surgical Treatment for Ischemic Heart Failure Trial

Researchers

Presenter

  • Lilin She

Principal Investigators

  • Kerry Lee

  • Guglielmo Stefanelli

  • William Hathaway

  • Cesare Beghi

  • Thao Hyunh

  • Eric Velazquez

  • Jae Oh

  • Rafal Dabrowski

  • Paul Grayburn

  • Miroslaw Rajda

  • David Prior

  • Patrice Desvigne-Nickens

  • William Zoghbi

  • Diane Miller

  • Michele Senni

Medical Centers

  • Ospedale Maggiore di Crema, Crema, Italy

  • St Vincent's Hospital, Melbourne, Australia

  • Mayo Clinic, Rochester, MN

  • Hesperia Hosp, Modena, Italy

  • Montreal General Hospital, MUHC, Montreal, QC, Canada

  • Mission St. Joseph Hosp, Asheville, NC

  • National Institute of Health, Bethesda, MD

  • Duke Clinical Research Institute, Durham, NC

  • Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada

  • Inst of Cardiology, Warsaw, Poland

  • Baylor Univ. Medical Ctr., Dallas, TX

  • Ospedali Riuniti di Bergamo, Bergamo, Italy

  • Methodist DeBakey, Houston, TX

Locations

  • Canada

  • Italy

  • Poland

  • Australia

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Coronary Artery Disease

  • Chronic ischemic left ventricular (LV) dysfunction

  • Diastolic dysfunction

  • Mitral valve regurgitation

  • Systolic dysfunction

  • Arrhythmia

  • Left ventricular dysfunction

  • Congestive heart failure

  • Diabetes

  • Anemia

  • Stroke

Biomarkers

  • Creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved